查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827386

显影剂市场按产品类型、影像方式、剂型、给药途径、应用和最终用户划分－全球预测 2025-2032

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年显影剂市场规模将成长至 123.5 亿美元，复合年增长率为 8.20%。

主要市场统计数据
基准年2024年 65.7亿美元
预计2025年 70.8亿美元
预测年份：2032年 123.5亿美元
复合年增长率（%） 8.20%

权威介绍，阐述了不断变化的临床需求、监管重点和供应链动态为何正在重新定义全球显影剂决策

显影剂是现代诊断影像的基石，使各专业的临床医生能够在製定治疗决策时，以高保真度可视化解剖学和生理学特征。诊断影像硬体、软体和显影剂化学的最新进展扩展了临床应用，同时也提高了监管机构的关注度和供应链审查力度。在此背景下，医院、诊断中心和门诊手术中心等相关人员越来越多地寻求能够平衡疗效和安全性、并针对患者併发症进行客製化的造影剂。因此，製造商、采购团队和临床负责人正在重新评估处方优先事项、筹资策略以及与设备和软体合作伙伴的合作模式。

此外，人们对个人化医疗和价值导向照护的期望日益增长，这正在改变显影剂的评估方式。付款人和医疗系统不再孤立地评估显影剂，而是寻求将显影剂的选择与诊断结果、后续护理途径和患者预后联繫起来的证据。同时，新的剂型和给药途径为给药和工作流程带来了实际考虑，影响了造影剂的采用。鑑于这些趋势，深入了解显影剂使用的临床和营运因素对于产品开发、市场拓展以及与临床指南的一致性至关重要。本介绍将为详细探讨结构性变化、关税影响、细分洞察、区域动态和策略建议奠定基础。

技术创新、监管力度加强以及更具弹性的供应链如何重新调整显影剂临床和商业相关人员的优先事项

显影剂造影剂市场格局正在经历变革时期，这得益于技术进步、监管格局的调整以及消费者预期的共同作用，这些因素正在重塑临床和市场行为。影像技术的创新，包括更高解析度的 CT 和 MRI 序列以及更先进的超音波平台，正在推动对造影更高、安全性更高的造影剂的需求。同时，製造商正在投资配方科学，以提高稳定性、降低不利事件发生率，并优化与下一代成像通讯协定的兼容性。

同时，随着监管机构加强上市后监管并完善药品安全指南，企业正在加强药物安全检测能力，并投资于真实世界证据的生成。全球疫情的衝击已将供应链韧性提升为策略重点，鼓励企业实现製造地多元化，并与製造外包更紧密地合作，以确保连续性。以病人为中心的医疗模式和付款人监督正在产生压力，要求企业透过与结果相关的证据和精简的医院工作流程来证明临床价值。这些趋势正在推动一个更一体化的生态系统，在这个生态系统中，製造商、临床医生、付款人和采购负责人必须在安全性、有效性和营运效率方面保持一致，以维持应用和创新。

评估新的关税现实如何促使策略采购调整、对本地製造的投资以及采购重新设计以保护临床供应的连续性

近期实施的关税和贸易政策调整为显影剂的全球筹资策略带来了新的复杂性，并对製造、分销和临床供应链产生了连锁反应。关税带来的成本压力促使供应商和经销商重新评估采购区域，评估本地生产的可行性，并与医疗保健提供者重新协商合约条款。因此，采购团队越来越关注总拥有成本 (TCO)，而不仅仅是单位成本，同时还要考虑物流、库存持有成本以及与替代采购安排相关的潜在合规费用。

为此，一些製造商正在加快对区域製造能力和伙伴关係关係的投资，以实现更灵活的供应安排。这些调整旨在降低跨境营运相关的营运风险，并维持对临床站点的持续存取。同时，医疗系统和诊断中心正在探索战略采购模式，例如框架协议和长期供应合同，以提供产量和价格的可预测性。透过这些调整，相关人员正在平衡对不间断临床供应的需求与不断变化的贸易政策带来的财务现实，在维护医疗服务的连续性的同时保护其组织的利润。

深度细分主导的洞察，将产品属性、临床模式、给药途径、应用和最终用户动态与策略决策联繫起来

粒度细分镜头揭示了显影剂领域的差异化动态，可为产品策略、临床采用和商业化策略提供资讯。依产品类型，市场分为钡基显影剂、钆基显影剂、碘基显影剂和微气泡显影剂，每个类别提供不同的物理化学特性、安全性和临床适应症。以显像模式，分析了电脑断层扫描 (CT)、磁振造影(MRI)、光学成像、超音波和 X 光/萤光透视法，反映了特定于方式对造影增强、时间分辨率和药物相容性的要求。根据形式，实际剂量和储存考虑区分液体、糊状和粉末製剂，影响库存管理和照护现场准备程序。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 与锁状化合物相比，大环钆药物的安全性更高，因此对大环钆药物的需求正在增加
  • 实施人工智慧驱动的演算法，根据患者生理特征和扫描方式调整显影剂剂剂量
  • 为了减少副作用，放射中心对低渗透碘显影剂的使用急剧增加。
  • 监管部门强调钆沉积的安全性，促使某些药物改变配方并撤出市场
  • 利用奈米粒子造影示踪剂进行标造影影像在肿瘤诊断与治疗监测的应用
  • 可携式CEUS 在急诊和严重监护中的应用日益广泛，推动了对超音波套件的需求。
  • 为了解决成像程序对环境的影响，该行业正在转向永续的显影剂处理和回收解决方案。

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章显影剂市场（依产品类型）

  • 钡基显影剂
  • 钆基显影剂
  • 碘化显影剂
  • 微气泡显影剂

第九章显影剂市场（依影像方式）

  • 电脑断层扫描（CT）
  • 磁振造影（MRI）
  • 光学成像
  • 超音波
  • X射线和萤光透视

第十章 对比显影剂市场（依形式）

  • 液体
  • 贴上
  • 粉末

第 11 章。按管理途径分類的显影剂市场

  • 血管内途径
  • 口服途径
  • 直肠途径

第十二章显影剂市场（依应用）

  • 癌症
  • 心血管疾病
  • 胃肠道疾病
  • 肌肉骨骼疾病
  • 肾臟疾病
  • 神经系统疾病

第 13 章。显影剂市场（按最终用户划分）

  • 门诊手术中心
  • 诊断影像中心
  • 医院

第十四章显影剂市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章显影剂市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章。各国显影剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Acro Lifesciences（I）Pvt. Ltd.
    • APOLLO RT Co. Ltd.
    • Bayer AG
    • Beijing Beilu Pharmaceutical Co., Ltd.
    • Bracco Spa
    • Covis Group
    • Daiichi Sankyo Co. Ltd.
    • Fuji Pharma Co. Ltd.
    • GE Healthcare
    • Guerbet SA
    • iMAX Diagnostic Imaging Limited
    • JB Chemicals & Pharmaceuticals Limited
    • Jodas Expoim Pvt. Ltd.
    • Lantheus Medical Imaging, Inc.
    • M.Biotech Limited
    • MEDTRON AG
    • nanoPET Pharma GmbH
    • SANOCHEMIA Pharmazeutika GmbH
    • Spago Nanomedical AB
    • Trivitron Healthcare
    • ulrich GmbH & Co. KG
    • Vitalquan, LLC
Product Code: MRR-434CCDA04E9E

The Contrast Media Market is projected to grow by USD 12.35 billion at a CAGR of 8.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.57 billion
Estimated Year [2025] USD 7.08 billion
Forecast Year [2032] USD 12.35 billion
CAGR (%) 8.20%

An authoritative introduction framing why evolving clinical needs, regulatory priorities, and supply chain dynamics are redefining contrast media decision-making worldwide

Contrast media remain a cornerstone of modern diagnostic imaging, enabling clinicians to visualize anatomy and physiology with fidelity that guides treatment decisions across a wide range of specialties. Recent advances in imaging hardware, software, and contrast agent chemistry have converged to expand clinical applications while intensifying regulatory attention and supply chain scrutiny. In this context, stakeholders across hospitals, diagnostic centers, and ambulatory surgical facilities increasingly demand agents that balance efficacy with safety profiles tailored to patient comorbidities. Consequently, manufacturers, procurement teams, and clinical leaders are reassessing formulary priorities, procurement strategies, and collaboration models with device and software partners.

Moreover, evolving expectations around personalized medicine and value-based care are shifting how contrast media are evaluated. Payers and health systems seek evidence that links contrast selection to diagnostic yield, downstream care pathways, and patient outcomes rather than evaluating agents in isolation. At the same time, novel delivery forms and routes introduce practical considerations for administration and workflow that influence adoption. In light of these developments, a nuanced understanding of the clinical and operational factors shaping contrast media utilization is essential for product development, market access, and clinical guideline alignment. This introduction sets the stage for deeper examination of structural shifts, tariff impacts, segmentation insights, regional dynamics, and strategic recommendations that follow.

How technological innovation, reinforced regulatory scrutiny, and supply chain resilience are collectively reshaping priorities across clinical and commercial stakeholders in contrast media

The contrast media landscape is undergoing transformative shifts driven by technological advances, regulatory recalibration, and consumer expectations that together are reshaping clinical practice and market behavior. Innovations in imaging modalities, including higher-resolution CT and MRI sequences and more sophisticated ultrasound platforms, have increased demand for agents that offer greater contrast differentiation while maintaining enhanced safety profiles. Concurrently, manufacturers are investing in formulation science to improve stability, reduce adverse event rates, and optimize compatibility with next-generation imaging protocols.

At the same time, regulators are intensifying post-market surveillance and refining guidance on agent safety, which has prompted companies to enhance pharmacovigilance capabilities and invest in real-world evidence generation. Supply chain resilience has emerged as a strategic priority following global disruptions, prompting diversification of manufacturing footprints and closer collaboration with contract manufacturers to safeguard continuity. Patient-centered care models and payer scrutiny are creating pressure to demonstrate clinical value through outcome-linked evidence and streamlined hospital workflows. Together, these trends are driving a more integrated ecosystem in which manufacturers, clinicians, payers, and procurement leaders must align on safety, effectiveness, and operational efficiency to sustain adoption and innovation.

Assessing how new tariff realities are prompting strategic sourcing adjustments, regional production investments, and procurement redesigns to protect clinical supply continuity

Recent tariff implementations and trade policy adjustments have introduced new layers of complexity into global procurement strategies for contrast media, with implications that reverberate through manufacturing, distribution, and clinical supply chains. Tariff-driven cost pressures have prompted suppliers and distributors to reassess sourcing geographies, evaluate the feasibility of localized production, and renegotiate contractual terms with healthcare providers. As a result, procurement teams are increasingly focusing on total cost of ownership rather than unit price alone, taking into account logistics, inventory carrying costs, and potential regulatory compliance expenditures associated with alternative sourcing arrangements.

In response, some manufacturers are accelerating investments in regional manufacturing capacity and in partnerships that enable more flexible supply arrangements. These adjustments aim to mitigate the operational risks associated with cross-border duties and to preserve stable access for clinical settings. Meanwhile, health systems and diagnostic centers are exploring strategic procurement models such as framework agreements and longer-term supply contracts that provide predictability in volumes and pricing. Through these adaptive measures, stakeholders seek to balance the need for uninterrupted clinical supply with the financial realities imposed by shifting trade policies, thereby maintaining continuity of care while protecting organizational margins.

Deep segmentation-driven insights that align product attributes, clinical modalities, administration routes, applications, and end-user dynamics to strategic decision-making

A granular segmentation lens reveals differentiated dynamics that inform product strategy, clinical adoption, and commercialization tactics across the contrast media domain. Based on Product Type, the market is examined through the lens of Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media, each category carrying distinct physicochemical properties, safety considerations, and clinical indications. Based on Imaging Modality, adoption patterns are analyzed across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Optical Imaging, Ultrasound, and X-Ray & Fluoroscopy, reflecting modality-specific requirements for contrast enhancement, temporal resolution, and agent compatibility. Based on Form, practical administration and storage considerations differentiate Liquid, Paste, and Powder formulations, which influence inventory management and point-of-care preparation routines.

Based on Route of Administration, clinical workflows and patient preparation vary markedly across Intravascular Route, Oral Route, and Rectal Route applications, shaping both safety protocols and nursing time allocation. Based on Application, therapeutic and diagnostic priorities across Cancer, Cardiovascular Diseases, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders dictate distinct performance benchmarks and evidence expectations. Based on End User, the procurement environment and utilization patterns differ across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals, each with unique budget cycles, clinical throughput, and regulatory oversight. Integrating these segmentation axes enables tailored market approaches that align product attributes with clinical needs, operational realities, and reimbursement considerations.

Regional dynamics and strategic approaches tailored to diverse regulatory regimes, healthcare infrastructures, and adoption patterns across major global regions

Regional variation in demand drivers, regulatory frameworks, and healthcare infrastructure produces distinct strategic imperatives across the world's major markets. In the Americas, market dynamics are shaped by consolidated hospital systems, widespread adoption of advanced imaging technologies, and payer models that emphasize clinical outcomes and cost-effectiveness; these conditions favor agents with robust safety data and clear operational advantages. Europe, Middle East & Africa present a heterogeneous regulatory environment where divergent national reimbursement approaches and variable infrastructure maturity create opportunities for differentiated market entry strategies, regional manufacturing partnerships, and targeted clinical evidence generation. In Asia-Pacific, rapid diagnostic capacity expansion, substantial investments in imaging infrastructure, and large patient populations are encouraging faster adoption cycles for new formulations and modality-specific agents, although procurement practices often vary by national policy and hospital tier.

Consequently, manufacturers and distributors must develop regionally nuanced strategies that account for local regulatory timelines, reimbursement landscapes, and distribution networks. Strategic collaborations with regional clinical opinion leaders and targeted real-world evidence programs can accelerate acceptance in markets with high clinical demand while addressing specific safety and logistical considerations. By aligning commercial models with regional healthcare system characteristics and clinician workflows, stakeholders can optimize access and ensure consistent supply across diverse operating environments.

Strategic company imperatives emphasizing rigorous manufacturing, evidence generation, and partnership-driven commercialization to secure clinical and procurement preference

Competitive positioning within the contrast media landscape depends on a combination of scientific differentiation, manufacturing reliability, regulatory compliance, and commercial partnerships. Leading organizations focus on portfolio depth and formulation innovation to meet modality-specific and application-specific needs, while emerging players concentrate on niche segments where novel chemistries or delivery forms can offer clear clinical advantages. Quality systems and GMP-compliant manufacturing are central to building trust with large hospital systems and diagnostic networks, and companies that demonstrate consistent supply reliability earn preferred supplier status in many procurement environments.

Furthermore, strategic alliances with imaging device manufacturers, clinical research networks, and distribution partners amplify reach and support evidence generation initiatives. Firms that invest in post-market surveillance and real-world outcomes studies strengthen their clinical narratives and facilitate smoother regulatory interactions. In addition, cost management through process efficiencies, contract manufacturing relationships, and inventory optimization enables competitive pricing without compromising margins. Together, these capabilities determine which companies can sustainably meet the evolving expectations of clinicians, procurement teams, and regulators while positioning themselves for long-term growth in increasingly sophisticated imaging markets.

Clear operational and clinical actions for leaders to strengthen product differentiation, supply resilience, and evidence-driven commercial strategies in contrast media

Industry leaders should pursue a set of actionable priorities that balance clinical innovation, supply resilience, and evidence-based commercialization to navigate near-term disruption and prepare for long-term adoption trends. First, invest in formulation and safety science to improve agent tolerability and to differentiate products for modality-specific use cases; this includes pursuing clinical studies and real-world evidence programs that tie contrast selection to diagnostic accuracy and patient outcomes. Second, prioritize supply chain diversification and regional manufacturing partnerships to reduce exposure to trade policy volatility and to ensure predictable availability across high-volume clinical settings. Third, align commercial strategies with end-user workflows by offering administration-ready formats and by supporting training initiatives that reduce time-to-adoption in busy imaging centers.

Additionally, develop payer engagement plans that articulate value in terms meaningful to decision-makers, such as reduced downstream procedures or improved diagnostic confidence. Strengthen partnerships with imaging hardware and software vendors to co-develop integrated solutions that optimize contrast utilization and image analytics. Finally, embed robust pharmacovigilance and post-market surveillance capabilities to sustain regulatory compliance and to build clinician trust. Taken together, these steps will help organizations achieve competitive advantage while safeguarding patient safety and operational continuity.

A transparent, reproducible research methodology combining primary stakeholder interviews and rigorous secondary evidence synthesis to validate clinical and commercial insights

This research synthesizes primary and secondary sources through a structured, reproducible methodology designed to capture clinical, regulatory, and commercial perspectives across the contrast media landscape. Primary inputs include stakeholder interviews with clinical end users, procurement specialists, and regulatory professionals to capture frontline experiences and to validate operational hypotheses. Secondary inputs draw on peer-reviewed clinical literature, regulatory advisories, manufacturing guidance, and publicly available institutional reports to build a comprehensive evidence base for safety profiles, modality requirements, and administrative practices. Data integrity is ensured through cross-validation of qualitative inputs against published clinical studies and regulatory documentation.

Analytical steps include segmentation mapping to align product attributes with clinical and operational use cases, scenario analysis to explore the implications of trade policy shifts and supply disruptions, and synthesis of regional regulatory considerations to inform market access strategies. Throughout the process, findings were reviewed by domain experts to ensure clinical relevance and to correct for potential bias. The methodology emphasizes transparency, reproducibility, and a pragmatic focus on decision-relevant insights that can inform procurement, clinical adoption, and product development strategies.

A concise conclusion emphasizing how innovation, evidence, and supply resilience will determine clinical adoption and commercial success in contrast media

In conclusion, the contrast media sector sits at an inflection point where scientific innovation, regulatory evolution, and logistical resilience converge to define competitive advantage. Advancements in imaging technology and formulation science are opening new clinical pathways, while payers and health systems demand stronger links between diagnostic choices and patient outcomes. Trade policy and supply chain volatility have reinforced the need for diversified manufacturing strategies and predictable distribution networks. Consequently, successful organizations will be those that couple demonstrable safety and efficacy with supply reliability and clear value narratives that resonate with clinicians and procurement leaders alike.

Looking ahead, the most impactful opportunities will arise from aligning product development with modality-specific demands, investing in real-world evidence that supports clinical and economic value, and forging partnerships that integrate contrast agents with imaging hardware and analytics platforms. By adopting these approaches, stakeholders can both safeguard clinical supply continuity and unlock new avenues for improved diagnostic care. The synthesis provided here is intended to support strategic choices that enhance patient safety, operational efficiency, and long-term commercial viability across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing demand for macrocyclic gadolinium agents due to enhanced safety profile over linear compounds
  • 5.2. Implementation of AI-driven algorithms to tailor contrast dosing based on patient physiology and scan modality
  • 5.3. Surge in low-osmolality iodinated contrast utilization in radiology centers aiming for reduced adverse reactions
  • 5.4. Regulatory emphasis on gadolinium deposition safety prompting reformulation and market withdrawal of certain agents
  • 5.5. Adoption of nanoparticle-based contrast tracers for targeted molecular imaging in oncology diagnostics and treatment monitoring
  • 5.6. Expansion of portable CEUS applications in emergency and critical care driving demand for ultrasound contrast media kits
  • 5.7. Industry shift towards sustainable contrast disposal and recycling solutions to address environmental impact of imaging procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Contrast Media Market, by Product Type

  • 8.1. Barium-based Contrast Media
  • 8.2. Gadolinium-based Contrast Media
  • 8.3. Iodinated Contrast Media
  • 8.4. Microbubble Contrast Media

9. Contrast Media Market, by Imaging Modality

  • 9.1. Computed Tomography (CT)
  • 9.2. Magnetic Resonance Imaging (MRI)
  • 9.3. Optical Imaging
  • 9.4. Ultrasound
  • 9.5. X-Ray & Fluoroscopy

10. Contrast Media Market, by Form

  • 10.1. Liquid
  • 10.2. Paste
  • 10.3. Powder

11. Contrast Media Market, by Route of Administration

  • 11.1. Intravascular Route
  • 11.2. Oral Route
  • 11.3. Rectal Route

12. Contrast Media Market, by Application

  • 12.1. Cancer
  • 12.2. Cardiovascular Diseases
  • 12.3. Gastrointestinal Disorders
  • 12.4. Musculoskeletal Disorders
  • 12.5. Nephrological Disorders
  • 12.6. Neurological Disorders

13. Contrast Media Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals

14. Contrast Media Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Contrast Media Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Contrast Media Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Acro Lifesciences (I) Pvt. Ltd.
    • 17.3.2. APOLLO RT Co. Ltd.
    • 17.3.3. Bayer AG
    • 17.3.4. Beijing Beilu Pharmaceutical Co., Ltd.
    • 17.3.5. Bracco Spa
    • 17.3.6. Covis Group
    • 17.3.7. Daiichi Sankyo Co. Ltd.
    • 17.3.8. Fuji Pharma Co. Ltd.
    • 17.3.9. GE Healthcare
    • 17.3.10. Guerbet SA
    • 17.3.11. iMAX Diagnostic Imaging Limited
    • 17.3.12. J. B. Chemicals & Pharmaceuticals Limited
    • 17.3.13. Jodas Expoim Pvt. Ltd.
    • 17.3.14. Lantheus Medical Imaging, Inc.
    • 17.3.15. M.Biotech Limited
    • 17.3.16. MEDTRON AG
    • 17.3.17. nanoPET Pharma GmbH
    • 17.3.18. SANOCHEMIA Pharmazeutika GmbH
    • 17.3.19. Spago Nanomedical AB
    • 17.3.20. Trivitron Healthcare
    • 17.3.21. ulrich GmbH & Co. KG
    • 17.3.22. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONTRAST MEDIA MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONTRAST MEDIA MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PASTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONTRAST MEDIA MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 296. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 297. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 298. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 299. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 300. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 301. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 338. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 339. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 340. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 341. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 342. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 343. G7 CONTRAST MEDIA MARK